Abstract
We assessed dermatologists’ knowledge and comfort levels in prescribing various medications. Knowledge gaps in the management of cyclophosphamide, opioid pain controllers, intravenous immunoglobulin and newer-generation biologics were observed. Dermatologists expressed greater concern about prescribing medications that are broadly immunosuppressive with severe side-effects such as cyclophosphamide and rituximab.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
